Pegylated interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C [1];Diabetes mellitus tipo 1 inducida por interferón pegilado en 2 pacientes con hepatitis crónica C

Gastroenterologia y Hepatologia

Volumn 27, Issue 2, 2004, Pages 69-

  Primo Vera, J ^a  

^a HOSPITAL DE SAGUNTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; HEMOGLOBIN A1C; INSULIN; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFECT; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HEPATITIS C; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LETTER; MALE; MONOTHERAPY; PATIENT MONITORING; POLYDIPSIA; POLYURIA;

EID: 10744229251     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056429     Document Type: Letter

References (9)

1. Fattovich G, Giustina G, Favarato S, Ruol A, Macarri G, Orlandi F, et al. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.
2. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-91.
3. Recasens M, Aguilera E, Ampurdanés S, Sánchez-Tapias JM, Simó O, Casamitjana R, et al. Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med 2001;18:764-7.
4. Fabris P, Floreani A, de Lazzari F, Betterle C, Greggio NA, Naccarato R, et al. Development of type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis. Lancet 1992;340:548.
5. Mofredj A, Howaizi M, Grasset D, Licht H, Loison S, Devergie B, et al. Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig Dis Sci 2002;47:1649-54.
6. Fabris P, Floreani A, Tositti G, Vergani D, de Lalla F, Betterle C. Review article: type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 2003;18:549-58.
7. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36 (Suppl):237-44.
8. Jabr FI, Ordinario MM. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy. Am J Med 2003;115:158-9.
9. Mehta SH, Strathdee SA, Thomas DL. Association between hepatitis C virus infection and diabetes mellitus. Epidemiol Rev 2001;23:302-12.